Physician profile
Paul B Williams
NPI 1982964508
$2,026.08
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,487 · 2022: $428 · 2023: $30.76 · 2024: $80.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.98 | 2021-2022 | |
| Novo Nordisk INC | $266.11 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $163.23 | 2021-2024 | Entyvio |
| Astrazeneca Pharmaceuticals LP | $145.69 | 2021-2022 | |
| Glaxosmithkline, LLC. | $119.18 | 2021-2022 | |
| Eisai INC. | $108.68 | 2021 | |
| Lilly USA, LLC | $79.29 | 2021-2024 | Jardiance |
| Pfizer INC. | $69.29 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $60.71 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.21 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $42.57 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $37.49 | 2021 | |
| Ironshore Pharmaceuticals INC. | $34.30 | 2021-2022 | |
| Dexcom, INC. | $32.56 | 2021 | |
| Axsome Therapeutics, INC. | $30.76 | 2023 | Auvelity |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $24.08 | 2021 | |
| Almatica Pharma LLC | $24.06 | 2022 | |
| Amgen INC. | $18.02 | 2022 | |
| Amarin Pharma, INC. | $17.69 | 2021 | |
| Alkermes, INC. | $16.70 | 2021 | |
| Mylan Specialty L.P. | $15.34 | 2022 | |
| Boston Scientific Corporation | $14.27 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $12.10 | 2021 | |
| Abbott Laboratories | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.